We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$342M
AUM Growth
+$51.1M
Cap. Flow
+$47.6M
Cap. Flow %
13.91%
Top 10 Hldgs %
10.44%
Holding
675
New
141
Increased
130
Reduced
57
Closed
344

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.02M
2
NKE icon
Nike
NKE
+$3.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$3.69M
4
BNY
Bank of New York Mellon
BNY
+$3.63M
5
COST icon
Costco
COST
+$3.41M

Top Sells

Rank Stock Value
1
PNC icon
PNC Financial Services
PNC
+$3.04M
2
V icon
Visa
V
+$2.98M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
PXD
Pioneer Natural Resource Co.
PXD
+$2.94M
5
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
+$2.82M

Sector Composition

Rank Sector Weight
1 Technology 15.97%
2 Industrials 12.49%
3 Consumer Discretionary 11.9%
4 Healthcare 11.63%
5 Consumer Staples 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GXP
626
DELISTED
Great Plains Energy Incorporated
GXP
– –
-37,001
Closed -$1.13M
MSCC
627
DELISTED
Microsemi Corp
MSCC
– –
-3,122
Closed -$102K
JUNO
628
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-1,001
Closed -$38K
SYT
629
DELISTED
Syngenta Ag
SYT
– –
-6,861
Closed -$527K
POT
630
DELISTED
Potash Corp Of Saskatchewan
POT
– –
-9,529
Closed -$155K
VWR
631
DELISTED
VWR Corporation
VWR
– –
-3,400
Closed -$98K
ALR
632
DELISTED
Alere Inc
ALR
– –
-2,500
Closed -$104K
CAB
633
DELISTED
Cabela's Inc
CAB
– –
-4,065
Closed -$203K
YHOO
634
DELISTED
Yahoo Inc
YHOO
– –
-13,319
Closed -$500K
ADPT
635
DELISTED
Adeptus Health Inc
ADPT
– –
-7,201
Closed -$372K
BEAV
636
DELISTED
B/E Aerospace Inc
BEAV
– –
-5,503
Closed -$254K
CSC
637
DELISTED
Computer Sciences
CSC
– –
-13,800
Closed -$685K
MENT
638
DELISTED
Mentor Graphics Corp
MENT
– –
-900
Closed -$19K
LLTC
639
DELISTED
Linear Technology Corp
LLTC
– –
-5,794
Closed -$270K
ARIA
640
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-15,800
Closed -$117K
VA
641
DELISTED
Virgin America Inc.
VA
– –
-1
Closed –
FEIC
642
DELISTED
FEI COMPANY
FEIC
– –
-14,000
Closed -$1.5M
STR
643
DELISTED
QUESTAR CORP
STR
– –
-6,700
Closed -$170K
EMC
644
DELISTED
EMC CORPORATION
EMC
– –
-67,775
Closed -$1.84M
RLYP
645
DELISTED
RELYPSA INC COM
RLYP
– –
-1,604
Closed -$30K
DWA
646
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
– –
-4,600
Closed -$188K
MKTO
647
DELISTED
MARKETO INC COM STK (DE)
MKTO
– –
-17,500
Closed -$609K
FMER
648
DELISTED
FIRSTMERIT CORP
FMER
– –
-34,700
Closed -$703K
FNFG
649
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
– –
-4,300
Closed -$42K
EXAM
650
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
– –
-3,700
Closed -$129K
23 24 25
26
27

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Seven Eight Capital held 675 positions worth $342M, up 18% from $291M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Seven Eight Capital deployed $47.6M of net new capital in Q3 2016, opening 141 new positions and adding to 130 existing holdings. Its largest new stake was Teva Pharmaceuticals: 77,100 shares worth $3.55M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Mastercard, an estimated $2.55M trimmed.

  • Seven Eight Capital's largest Q3 2016 buy was Teva Pharmaceuticals: 77,100 shares worth $3.55M.
  • Seven Eight Capital added most to Bristol-Myers Squibb in Q3 2016, an estimated $3.69M increase.
  • Seven Eight Capital's biggest Q3 2016 reduction was Mastercard, cutting an estimated $2.55M.
  • Seven Eight Capital fully exited PNC Financial Services in Q3 2016, selling an estimated $3.04M.
  • Seven Eight Capital's ten largest holdings make up 10% of its $342M portfolio in Q3 2016.
  • Seven Eight Capital opened 141 new positions and closed 344 in Q3 2016.
  • Seven Eight Capital's portfolio value rose 18% quarter-over-quarter to $342M.

Based on Seven Eight Capital's 13F filing for Q3 2016, filed 14 Nov 2016.